Drug Discovery & Development

<img alt="" height="1" width="1" />
Delcath Fires CEO, Explores Strategic Options
Wall Street Journal
Delcath Systems Inc. (DCTH) terminated Chief Executive Eamonn P. Hobbs, while appointing a transition committee that will help it explore strategic options. Mr. Hobbs&#39;s dismissal was effective Monday. He also resigned from the board. Meanwhile ...
FDA rejects Delcath&#39;s cancer therapy, asks for more trialsReuters
Delcath gets FDA denial on cancer treatment and axes CEOFierceBiotech
Hobbs out as Delcath CEOThe Business Review (Albany)
Glens Falls Post-Star -MarketWatch
all 7 news articles &raquo;